Accendra Health Inc.

ACHUnited States

29 filed reports · 594 financial concepts · 12 earnings calls

Latest figures

Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.

Latest fiscal year

Revenue

$2.76B

FY2025 · to Dec 31, 2025

up +3.1% vs $2.68B

10-K

Net income

-$1.1B

FY2025 · to Dec 31, 2025

a year earlier: -$363M

10-K

Operating income

$27.5M

FY2025 · to Dec 31, 2025

a year earlier: -$218M

10-K

Latest quarter

Revenue

$602M

Q3 FY2026 · to Sep 30, 2026

down −13.7% vs $697M

10-Q

Net income

-$19.7M

Q3 FY2026 · to Sep 30, 2026

a year earlier: -$150M

10-Q

Operating income

$1.33M

Q3 FY2026 · to Sep 30, 2026

down −95.0% vs $26.5M

10-Q

Filed reports

29 reports · Dec 2019 to Sep 2026

Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 209 earnings-release figures, 22 commentary passages.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR213,937Mar 2020 to Sep 2026
Annual · 10-KSEC EDGAR73,935Dec 2019 to Dec 2025
Current · 8-KSEC EDGAR1169Sep 2026

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q310-Q2026-09-302026-11-06361Open
FY2026 Q38-K2026-09-302026-11-05169Open
FY2026 Q210-Q2026-06-302026-08-10217Open
FY2026 Q110-Q2026-03-312026-05-11210Open
FY202510-K2025-12-312026-02-20917Open
FY2025 Q310-Q2025-09-302025-10-31226Open
FY2025 Q210-Q2025-06-302025-08-11230Open
FY2025 Q110-Q2025-03-312025-05-08180Open
FY202410-K2024-12-312025-02-28693Open
FY2024 Q310-Q2024-09-302024-11-04188Open
FY2024 Q210-Q2024-06-302024-08-02180Open
FY2024 Q110-Q2024-03-312024-05-03153Open

Financial data

594 concepts · 8,041 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial514 concepts · 7,131 facts · Dec 2018 to Sep 2026

  • Changes in operating lease right-of-use assets and lease liabilities42 · Dec 2018 to Sep 2026
  • Common stock par or stated value per share40 · Dec 2018 to Sep 2026
  • Restructuring reserve40 · Dec 2018 to Sep 2026
  • Stockholders equity (US GAAP)40 · Dec 2018 to Sep 2026
  • Amortization of intangible assets39 · Dec 2018 to Sep 2026
  • Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect39 · Dec 2018 to Sep 2026
  • Comprehensive income net of tax39 · Dec 2018 to Sep 2026
  • Cost of revenue (US GAAP)39 · Dec 2018 to Sep 2026
  • Depreciation depletion and amortization39 · Dec 2018 to Sep 2026
  • Effect of exchange rate on cash cash equivalents restricted cash and restricted cash equivalents39 · Dec 2018 to Sep 2026
  • Income taxes paid net39 · Dec 2018 to Sep 2026
  • Income tax expense benefit39 · Dec 2018 to Sep 2026
  • Increase decrease in accounts and notes receivable39 · Dec 2018 to Sep 2026
  • Increase decrease in accounts payable trade39 · Dec 2018 to Sep 2026
  • Increase decrease in inventories39 · Dec 2018 to Sep 2026
  • Increase decrease in other operating capital net39 · Dec 2018 to Sep 2026
  • Interest paid net39 · Dec 2018 to Sep 2026
  • Net cash provided by used in financing activities39 · Dec 2018 to Sep 2026
  • Net cash provided by used in investing activities39 · Dec 2018 to Sep 2026
  • Net income loss39 · Dec 2018 to Sep 2026
  • Nonoperating income expense39 · Dec 2018 to Sep 2026
  • Operating income loss39 · Dec 2018 to Sep 2026
  • Payments for software39 · Dec 2018 to Sep 2026
  • Payments to acquire property plant and equipment39 · Dec 2018 to Sep 2026

Segment22 concepts · 531 facts · Dec 2018 to Mar 2025

  • Operating income loss76 · Dec 2018 to Mar 2025
  • Revenue76 · Dec 2018 to Mar 2025
  • Goodwill foreign currency translation gain loss56 · Dec 2018 to Mar 2025
  • Business exit costs154 · Dec 2018 to Dec 2022
  • Depreciation depletion and amortization52 · Dec 2018 to Mar 2025
  • Payments to acquire productive assets46 · Dec 2018 to Sep 2024
  • Goodwill acquired during period25 · Dec 2018 to Dec 2023
  • Allocated share based compensation expense20 · Dec 2021 to Sep 2024
  • Depreciation, Depletion and Amortization, Continuing Operations18 · Mar 2019 to Sep 2021
  • Property plant and equipment additions18 · Mar 2019 to Sep 2021
  • Inventory Non-cash Adjustments12 · Dec 2022 to Mar 2025
  • Property plant and equipment disposals12 · Dec 2022 to Mar 2025
  • Cost of revenue (US GAAP)10 · Dec 2022 to Mar 2025
  • Other operating income expense net10 · Dec 2022 to Mar 2025
  • Selling general and administrative expense10 · Dec 2022 to Mar 2025
  • Share based compensation10 · Dec 2022 to Mar 2025
  • Segment expenditure addition to long lived assets8 · Dec 2022 to Mar 2025
  • Inventory write down5 · Dec 2022 to Mar 2025
  • Restructuring and related cost incurred cost5 · Mar 2024 to Dec 2024
  • Direct costs of leased and rented property or equipment3 · Dec 2022 to Dec 2024
  • Goodwill impairment loss3 · Dec 2018 to Dec 2024
  • Goodwill purchase accounting adjustments2 · Dec 2019

KPI51 concepts · 163 facts · Sep 2025 to Sep 2026

  • Other (9)10 · Sep 2025 to Sep 2026
  • Other, net10 · Sep 2025 to Sep 2026
  • Net loss8 · Sep 2025 to Sep 2026
  • Litigation and related charges (5)5 · Sep 2025 to Sep 2026
  • Accounts payable4 · Sep 2025 to Sep 2026
  • Accounts receivable, net4 · Sep 2025 to Sep 2026
  • Accrued interest expense4 · Sep 2025 to Sep 2026
  • Accrued payroll and related liabilities4 · Sep 2025 to Sep 2026
  • Additions to computer software4 · Sep 2025 to Sep 2026
  • Borrowings under Revolving Credit Agreement4 · Sep 2025 to Sep 2026
  • Cash provided by (used for) investing activities4 · Sep 2025 to Sep 2026
  • Cash (used for) provided by financing activities4 · Sep 2025 to Sep 2026
  • Deferred income tax benefit4 · Sep 2025 to Sep 2026
  • Depreciation and amortization4 · Sep 2025 to Sep 2026
  • Income tax benefit on pre-tax adjustments (11)4 · Sep 2025 to Sep 2026
  • Income taxes paid, net4 · Sep 2025 to Sep 2026
  • Inventories4 · Sep 2025 to Sep 2026
  • Net change in other assets and liabilities4 · Sep 2025 to Sep 2026
  • Net revenue4 · Sep 2025 to Sep 2026
  • Non-cash convert to sale write off expense (10)4 · Sep 2025 to Sep 2026
  • Other depreciation and amortization (6)4 · Sep 2025 to Sep 2026
  • Patient service equipment capital expenditures4 · Sep 2025 to Sep 2026
  • Proceeds from sale of patient service equipment4 · Sep 2025 to Sep 2026
  • Repayments under Revolving Credit Agreement4 · Sep 2025 to Sep 2026

Product5 concepts · 150 facts · Dec 2018 to Sep 2026

  • Revenue116 · Dec 2023 to Sep 2026
  • Selling general and administrative expense16 · Dec 2018 to Dec 2025
  • Direct costs of leased and rented property or equipment13 · Dec 2020 to Sep 2024
  • Depreciation3 · Dec 2020 to Dec 2022
  • Revenue, Leased And Rented Property Or Equipment2 · Sep 2022 to Sep 2023

Geography1 concept · 64 facts · Dec 2018 to Mar 2025

  • Revenue64 · Dec 2018 to Mar 2025

Guidance1 concept · 2 facts · Nov 2026

  • Revenue Guidance2 · Nov 2026

Segments

745 facts

Figures broken down by business line, region, product or another axis the company reports on.

Statement business segments4 members · 531 facts

  • Products & Healthcare Services180 · Dec 2020 to Mar 2025
  • Patient Direct171 · Dec 2020 to Mar 2025
  • Global Products90 · Dec 2018 to Dec 2021
  • Global Solutions90 · Dec 2018 to Dec 2021

Product or service10 members · 150 facts

  • Diabetes Product17 · Dec 2023 to Sep 2026
  • Home Respiratory Therapy Product17 · Dec 2023 to Sep 2026
  • Ostomy17 · Dec 2023 to Sep 2026
  • Sleep Therapy Product17 · Dec 2023 to Sep 2026
  • Urology17 · Dec 2023 to Sep 2026
  • Wound Care17 · Dec 2023 to Sep 2026
  • Shipping And Handling16 · Dec 2018 to Dec 2025
  • Rental Equipment15 · Dec 2020 to Sep 2024
  • Product And Service Other14 · Dec 2023 to Sep 2026
  • Equipment3 · Dec 2020 to Dec 2022

Statement geographical2 members · 64 facts

  • International32 · Dec 2018 to Mar 2025
  • United States32 · Dec 2018 to Mar 2025

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

  • Earnings-release commentary5 claims from 1 report · Sep 2026
  • Management discussion (MD&A) commentary17 claims from 1 report · Sep 2026

Earnings calls

12 calls · Feb 2024 to Nov 2026

Transcripts with management claims and analyst questions, one per fiscal period.

  • FY2026 Q32026-11-05
  • FY2026 Q22026-08-10
  • FY2026 Q12026-05-11
  • FY2025 Q42026-02-19
  • FY2025 Q32025-10-30
  • FY2025 Q22025-08-11
  • FY2025 Q12025-05-08
  • FY2024 Q42025-02-28
  • FY2024 Q32024-11-04
  • FY2024 Q22024-08-02
  • FY2024 Q12024-05-03
  • FY2023 Q42024-02-20

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Ask about this company in your AI model

Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.

Use FactIQ to get the revenue, net income and operating income of Accendra Health Inc. (ACH) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.

Works once FactIQ is connected

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 21, 2026) and refreshed every few hours.

Accendra Health Inc. (ACH): FY2025 revenue $2.76B · FactIQ